NCT01624506

Brief Summary

The Anti-Reflux Surgical Study has been established to:

  • Collect data about anti-reflux surgical treatment options (magnetic sphincter augmentation and Fundoplication) in everyday clinical practice
  • Track the clinical course of patients from pre-operative assessment to three years post-surgery

Trial Health

90
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
760

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2010

Longer than P75 for all trials

Geographic Reach
4 countries

21 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2010

Completed
2.5 years until next milestone

First Submitted

Initial submission to the registry

June 18, 2012

Completed
2 days until next milestone

First Posted

Study publicly available on registry

June 20, 2012

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2015

Completed
3.5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2018

Completed
2.9 years until next milestone

Results Posted

Study results publicly available

June 8, 2021

Completed
Last Updated

June 8, 2021

Status Verified

May 1, 2021

Enrollment Period

5 years

First QC Date

June 18, 2012

Results QC Date

April 19, 2021

Last Update Submit

May 13, 2021

Conditions

Keywords

Gastroesophageal Reflux DiseaseFundoplicationMagnetic Sphincter AugmentationProton Pump InhibitorsGERDPPIMSA

Outcome Measures

Primary Outcomes (1)

  • Gastroesophageal Reflux Disease Health Related Quality of Life Outcome (GERD-HRQL)

    Gastroesophageal Reflux Disease Health Related Quality of Life Outcomes (GERD-HRQL) Total scores range from 0-50 (min/max) 10 questions total, each rating 0-5 (min/max) Lower is better; higher is worse

    3 years post-surgery

Study Arms (2)

Magnetic Sphincter Augmentation

Patients will be treated with magnetic sphincter augmentation via the LINX Reflux Management System

Fundoplication

Patients treated with laparoscopic fundoplication

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients undergoing antireflux surgery for the treatment of gastroesophageal reflux disease (GERD)

You may qualify if:

  • Individuals treated with LINX Reflux Management System or Fundoplication
  • Individuals who have provided appropriate authorization per institutional policy and procedure to have clinical and health information collected for the Anti-Reflux Surgical Registry.
  • Individuals willing to complete questionnaires and comply with the three years of follow-up.

You may not qualify if:

  • Known circumstances that would make it unlikely for an individual to complete the three year follow-up (e.g. life expectancy \<3 years)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (21)

AKH Wien

Vienna, Austria

Location

Herz Jesu Krankenhaus

Vienna, Austria

Location

MIC Klinik Berlin

Berlin, Germany

Location

Knappschafts Krankenhaus Bottrop

Bottrop, Germany

Location

Diako Bremen

Bremen, Germany

Location

Krankenhaus Castrop Rauxel

Castrop-Rauxel, Germany

Location

Uniklinikum Koln

Cologne, Germany

Location

Klinikum Forchheim

Forchheim, Germany

Location

Krankenhaus Herne

Herne, Germany

Location

Marien Krankenhaus

Kassel, Germany

Location

Arabella Klinik

München, Germany

Location

Ruppiner Kliniken

Neuruppin, Germany

Location

Stadtkrankenhaus Schwabach

Schwabach, Germany

Location

St. Rochus

Telgte, Germany

Location

Ev. K Zweibrucken

Zweibrücken, Germany

Location

Policlinico San Donato

Milan, Italy

Location

Reflux Centre

Birmingham, United Kingdom

Location

Epsom and St. Helier Hospital

Epsom, United Kingdom

Location

Royal Devon & Exeter Hospital

Exeter, United Kingdom

Location

Spire Tunbridge Wells Hospital

Royal Tunbridge Wells, United Kingdom

Location

Weymouth Hospital

Weymouth, United Kingdom

Location

Related Publications (2)

  • Bonavina L, Horbach T, Schoppmann SF, DeMarchi J. Three-year clinical experience with magnetic sphincter augmentation and laparoscopic fundoplication. Surg Endosc. 2021 Jul;35(7):3449-3458. doi: 10.1007/s00464-020-07792-1. Epub 2020 Jul 16.

  • Riegler M, Schoppman SF, Bonavina L, Ashton D, Horbach T, Kemen M. Magnetic sphincter augmentation and fundoplication for GERD in clinical practice: one-year results of a multicenter, prospective observational study. Surg Endosc. 2015 May;29(5):1123-9. doi: 10.1007/s00464-014-3772-7. Epub 2014 Aug 30.

MeSH Terms

Conditions

Gastroesophageal Reflux

Condition Hierarchy (Ancestors)

Esophageal Motility DisordersDeglutition DisordersEsophageal DiseasesGastrointestinal DiseasesDigestive System Diseases

Results Point of Contact

Title
Janet DeMarchi
Organization
Ethicon

Publication Agreements

PI is Sponsor Employee
No
Restriction Type
OTHER
Restrictive Agreement
Yes

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
OTHER
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 18, 2012

First Posted

June 20, 2012

Study Start

January 1, 2010

Primary Completion

January 1, 2015

Study Completion

July 1, 2018

Last Updated

June 8, 2021

Results First Posted

June 8, 2021

Record last verified: 2021-05

Locations